Literature DB >> 19893576

IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis.

Julia Bollrath1, Florian R Greten.   

Abstract

Our understanding of the molecular mechanisms that link inflammation and cancer has significantly increased in recent years. Here, we analyse genetic evidence indicating that the transcription factors nuclear factor-kappaB (NF-kappaB) and signal transducer and activator of transcription 3 (STAT3) have a central role in this context by regulating distinct functions in cancer cells and surrounding non-tumorigenic cells. In immune cells, NF-kappaB induces the transcription of genes that encode pro-inflammatory cytokines, which can act in a paracrine manner on initiated cells. By contrast, in tumorigenic cells, both NF-kappaB and STAT3 control apoptosis, and STAT3 can also enhance proliferation. Consequently, inflammation should be considered as a valuable target for cancer prevention and therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19893576      PMCID: PMC2799209          DOI: 10.1038/embor.2009.243

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  60 in total

Review 1.  Inflammation and necrosis promote tumour growth.

Authors:  Jukka Vakkila; Michael T Lotze
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

Review 2.  The STATs of cancer--new molecular targets come of age.

Authors:  Hua Yu; Richard Jove
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

3.  A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells.

Authors:  Hui Song; Renxiao Wang; Shaomeng Wang; Jiayuh Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

4.  IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.

Authors:  Shin Maeda; Hideaki Kamata; Jun-Li Luo; Hyam Leffert; Michael Karin
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

Review 5.  Hepatocellular carcinoma: epidemiology, risk factors, and screening.

Authors:  Morris Sherman
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

6.  TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

Authors:  Christoph Becker; Massimo C Fantini; Christoph Schramm; Hans A Lehr; Stefan Wirtz; Alexei Nikolaev; Jürgen Burg; Susanne Strand; Ralf Kiesslich; Samuel Huber; Hiroaki Ito; Norihiro Nishimoto; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Peter R Galle; Manfred Blessing; Stefan Rose-John; Markus F Neurath
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

7.  NF-kappaB functions as a tumour promoter in inflammation-associated cancer.

Authors:  Eli Pikarsky; Rinnat M Porat; Ilan Stein; Rinat Abramovitch; Sharon Amit; Shafika Kasem; Elena Gutkovich-Pyest; Simcha Urieli-Shoval; Eithan Galun; Yinon Ben-Neriah
Journal:  Nature       Date:  2004-08-25       Impact factor: 49.962

8.  IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.

Authors:  Florian R Greten; Lars Eckmann; Tim F Greten; Jin Mo Park; Zhi-Wei Li; Laurence J Egan; Martin F Kagnoff; Michael Karin
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

9.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

10.  Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice.

Authors:  Niall C Tebbutt; Andrew S Giraud; Melissa Inglese; Brendan Jenkins; Paul Waring; Fiona J Clay; Sina Malki; Barbara M Alderman; Dianne Grail; Frédéric Hollande; Joan K Heath; Matthias Ernst
Journal:  Nat Med       Date:  2002-09-09       Impact factor: 53.440

View more
  155 in total

1.  The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.

Authors:  Lauren L C Marotta; Vanessa Almendro; Andriy Marusyk; Michail Shipitsin; Janina Schemme; Sarah R Walker; Noga Bloushtain-Qimron; Jessica J Kim; Sibgat A Choudhury; Reo Maruyama; Zhenhua Wu; Mithat Gönen; Laura A Mulvey; Marina O Bessarabova; Sung Jin Huh; Serena J Silver; So Young Kim; So Yeon Park; Hee Eun Lee; Karen S Anderson; Andrea L Richardson; Tatiana Nikolskaya; Yuri Nikolsky; X Shirley Liu; David E Root; William C Hahn; David A Frank; Kornelia Polyak
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Breaking the NF-κB and STAT3 alliance inhibits inflammation and pancreatic tumorigenesis.

Authors:  Young-Joon Surh; Ann M Bode; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-26

3.  TNIP1, a retinoic acid receptor corepressor and A20-binding inhibitor of NF-κB, distributes to both nuclear and cytoplasmic locations.

Authors:  Igor Gurevich; Carmen Zhang; Nidhish Francis; Brian J Aneskievich
Journal:  J Histochem Cytochem       Date:  2011-12       Impact factor: 2.479

4.  Peering into the aftermath: JAKi rips STAT3 in cancer.

Authors:  Florian R Greten; Michael Karin
Journal:  Nat Med       Date:  2010-10       Impact factor: 53.440

Review 5.  NF-κB signaling in cancer stem cells: a promising therapeutic target?

Authors:  K Vazquez-Santillan; J Melendez-Zajgla; L Jimenez-Hernandez; G Martínez-Ruiz; V Maldonado
Journal:  Cell Oncol (Dordr)       Date:  2015-08-29       Impact factor: 6.730

6.  Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesis.

Authors:  K K Gkouskou; M Ioannou; G A Pavlopoulos; K Georgila; A Siganou; G Nikolaidis; D C Kanellis; S Moore; K A Papadakis; D Kardassis; I Iliopoulos; F A McDyer; E Drakos; A G Eliopoulos
Journal:  Oncogene       Date:  2015-08-17       Impact factor: 9.867

Review 7.  NF-κB and STAT3 - key players in liver inflammation and cancer.

Authors:  Guobin He; Michael Karin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

8.  Lipopolysaccharide enhances mouse lung tumorigenesis: a model for inflammation-driven lung cancer.

Authors:  T Melkamu; X Qian; P Upadhyaya; M G O'Sullivan; F Kassie
Journal:  Vet Pathol       Date:  2013-02-04       Impact factor: 2.221

9.  miR-124 functions as a tumor suppressor in the endometrial carcinoma cell line HEC-1B partly by suppressing STAT3.

Authors:  Yunyun Li; Zhongzu Zhang; Xiuxia Liu; Tingting Huang; Wenfeng He; Yang Shen; Xin Liu; Kui Hong; Qing Cao
Journal:  Mol Cell Biochem       Date:  2013-11-28       Impact factor: 3.396

10.  Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis.

Authors:  Paul K Ziegler; Julia Bollrath; Charles K Pallangyo; Takaji Matsutani; Özge Canli; Tiago De Oliveira; Michaela A Diamanti; Nina Müller; Jaba Gamrekelashvili; Tracy Putoczki; David Horst; Arun K Mankan; Meryem G Öner; Susanna Müller; Josef Müller-Höcker; Thomas Kirchner; Julia Slotta-Huspenina; M Mark Taketo; Thomas Reinheckel; Stefan Dröse; Andrew C Larner; Winfried S Wels; Matthias Ernst; Tim F Greten; Melek C Arkan; Thomas Korn; Dagmar Wirth; Florian R Greten
Journal:  Cell       Date:  2018-06-14       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.